Ambu AS is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care... Show more
The Stochastic Oscillator for AMBBY moved out of overbought territory on September 23, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 62 similar instances where the indicator exited the overbought zone. In of the 62 cases the stock moved lower. This puts the odds of a downward move at .
The 10-day RSI Indicator for AMBBY moved out of overbought territory on August 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
AMBBY broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on September 24, 2025. You may want to consider a long position or call options on AMBBY as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AMBBY just turned positive on September 16, 2025. Looking at past instances where AMBBY's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
AMBBY moved above its 50-day moving average on September 16, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AMBBY crossed bullishly above the 50-day moving average on September 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AMBBY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.374) is normal, around the industry mean (60.267). P/E Ratio (72.377) is within average values for comparable stocks, (37.392). AMBBY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.697). AMBBY has a moderately low Dividend Yield (0.004) as compared to the industry average of (0.020). P/S Ratio (4.352) is also within normal values, averaging (78.998).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMBBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Industry MedicalNursingServices
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JPI | 20.68 | N/A | N/A |
Nuveen Preferred Securities & Income Opportunities Fund | |||
FIXP | 19.85 | N/A | N/A |
FolioBeyond Enhanced Fixed Inc Prm ETF | |||
QVML | 38.80 | -0.13 | -0.34% |
Invesco S&P 500 QVM Multi-factor ETF | |||
GSJY | 45.23 | -0.26 | -0.56% |
Goldman Sachs ActiveBeta® Japan Eq ETF | |||
DULL | 2.76 | -0.03 | -0.90% |
MicroSectors™ Gold -3X Inverse Lvrgd ETN |
A.I.dvisor indicates that over the last year, AMBBY has been loosely correlated with ICCM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMBBY jumps, then ICCM could also see price increases.
Ticker / NAME | Correlation To AMBBY | 1D Price Change % | ||
---|---|---|---|---|
AMBBY | 100% | N/A | ||
ICCM - AMBBY | 35% Loosely correlated | -1.90% | ||
MDXH - AMBBY | 34% Loosely correlated | -1.83% | ||
VTAK - AMBBY | 25% Poorly correlated | -5.04% | ||
SAFLF - AMBBY | 24% Poorly correlated | N/A | ||
CLPBY - AMBBY | 23% Poorly correlated | -4.58% | ||
More |
Ticker / NAME | Correlation To AMBBY | 1D Price Change % |
---|---|---|
AMBBY | 100% | N/A |
Medical/Nursing Services industry (226 stocks) | 8% Poorly correlated | -0.15% |
Health Services industry (438 stocks) | 2% Poorly correlated | -0.03% |